Emerging drugs for idiopathic pulmonary fibrosis
Emerging drugs for idiopathic pulmonary fibrosis
The treatment of IPF represents one of the greatest challenges confronting respiratory medicine and, currently, there is no effective therapeutic option for IPF. Perhaps some of the drugs that are under evaluation in clinical trials will slow the decline of the pulmonary function tests or hopefully stabilize some patients. Nonetheless, it appears clear that new therapeutic approaches are urgently needed.
341-362
Selman, Moisés
42c44609-778c-4180-9ffc-fa913a68fbf8
Pardo, Annie
3d1747a4-6c1d-468b-bf5b-4368b6ffccef
Richeldi, Luca
47177d9c-731a-49a1-9cc6-4ac8f6bbbf26
Cerri, Stefania
7ea9bc28-eaf2-46ce-8433-b9e732484b5f
June 2011
Selman, Moisés
42c44609-778c-4180-9ffc-fa913a68fbf8
Pardo, Annie
3d1747a4-6c1d-468b-bf5b-4368b6ffccef
Richeldi, Luca
47177d9c-731a-49a1-9cc6-4ac8f6bbbf26
Cerri, Stefania
7ea9bc28-eaf2-46ce-8433-b9e732484b5f
Abstract
The treatment of IPF represents one of the greatest challenges confronting respiratory medicine and, currently, there is no effective therapeutic option for IPF. Perhaps some of the drugs that are under evaluation in clinical trials will slow the decline of the pulmonary function tests or hopefully stabilize some patients. Nonetheless, it appears clear that new therapeutic approaches are urgently needed.
This record has no associated files available for download.
More information
Published date: June 2011
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 369081
URI: http://eprints.soton.ac.uk/id/eprint/369081
ISSN: 1472-8214
PURE UUID: ab150b9a-7eda-4c31-be0b-98ff74c2e261
Catalogue record
Date deposited: 24 Sep 2014 11:57
Last modified: 14 Mar 2024 17:57
Export record
Altmetrics
Contributors
Author:
Moisés Selman
Author:
Annie Pardo
Author:
Luca Richeldi
Author:
Stefania Cerri
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics